The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|1|119-132

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.1, 2011-02, pp. : 119-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

By Howland Robert H.  

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 709-731

Adis International

Access to resources Recommend Favorite

A review of the efficacy and tolerability of agomelatine in the treatment of major depression

By Ghosh Anita   Hellewell Jonathan SE  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1999-2004

Informa Healthcare

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M   Shelton Richard C  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

Role of melatonin in mood disorders and the antidepressant effects of agomelatine

By Srinivasan Venkataramanujam   De Berardis Domenico   Shillcutt Samuel D   Brzezinski Amnon  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1503-1522

Informa Healthcare

Access to resources Recommend Favorite

Melatonin Receptor Agonist Agomelatine: A New Drug for Treating Unipolar Depression

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1675-1682

Bentham Science Publishers

Access to resources Recommend Favorite